Tarsus Pharmaceuticals TARS
NASDAQ TARS
$73.00 -2.46 (-3.26%)
At close: Oct 2, 2026 · 4:00 PM EDT

Tarsus Pharmaceuticals (TARS) Return on Sales [ROS] (2021 - 2026)

Updated

Tarsus Pharmaceuticals' Return on Sales [ROS] came in at -11.45% for Q2 2026, up 10.16 percentage points from -21.61% a year earlier but down 7.67 percentage points from the prior quarter.

Analysis

Tarsus Pharmaceuticals (TARS) Return on Sales [ROS] (2021 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Tarsus Pharmaceuticals reported Return on Sales [ROS] of -8.00%, up 25.17 percentage points year-over-year; for FY2025, it came in at -15.72%, up 50.18 percentage points from FY2024.

  • Return on Sales [ROS] carries a four-year change of +5.59 percentage points (FY2021 to FY2025).
  • Going back by year, Return on Sales [ROS] was -65.90% in FY2024 (+754.63 pp), -820.53% in FY2023 (-577.61 pp), -242.92% in FY2022 (-221.60 pp) and -21.32% in FY2021.
  • The five-year range for quarterly Return on Sales [ROS] is -4274.56% (Q4 2021) to -3.78% (Q1 2026).
  • Year-over-year, Return on Sales [ROS] has increased for ten consecutive quarters, with an average year-over-year change of +339.14 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Sales [ROS] over five years came in Q4 2022 (a gain of 4123.95 percentage points), and the weakest in Q1 2022 (a drop of 3653.75 percentage points).
  • Business Quant data shows TARS's Return on Sales [ROS] at -3.78% (Q1 2026), -5.26% (Q4 2025) and -12.24% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 28.21%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 37.86%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -3.52%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 32.97%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 20.57%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 34.95%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -133.21%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 28.37%
10 Tarsus Pharmaceuticals 3.16 Bn 2.10 Bn 161.80 Mn -11.45%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -11.45%
Mar 31, 2026 -3.78%
Dec 31, 2025 -5.26%
Sep 30, 2025 -12.24%
Jun 30, 2025 -21.61%
Mar 31, 2025 -33.55%
Dec 31, 2024 -36.77%
Sep 30, 2024 -52.29%
Jun 30, 2024 -81.60%
Mar 31, 2024 -136.47%
Dec 31, 2023 -339.94%
Sep 30, 2023 -2,187.87%
Jun 30, 2023 -765.92%
Mar 31, 2023 -998.08%
Dec 31, 2022 -150.61%
Sep 30, 2022 -384.42%
Jun 30, 2022 -34.20%
Mar 31, 2022 -3,621.71%
Dec 31, 2021 -4,274.56%
Sep 30, 2021 -1,266.53%
API Access

Tarsus Pharmaceuticals Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=TARS&period=max&api_key=YOUR_API_KEY